Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples